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The Temporal Importance of TNFa Expression
in the Development of Diabetes
In insulin-dependent diabetes mellitus (IDDM), the is-
lets of Langerhans become infiltrated with immune cells
that subsequently destroy the insulin-producing b cells
E. Allison Green* and Richard A. Flavell*²³
*Yale University School of Medicine and
²Howard Hughes Medical Institute
by T cell±mediated mechanisms (Delovitch and Singh,Section of Immunobiology
1997). A wealth of information from studies in mice eitherNew Haven, Connecticut 06520
genetically predisposed or nondisposed to developing
IDDM has highlighted that breakdown in peripheral toler-
ance to islet antigen can be engineered by a vast number
Summary of cellular and molecular mediators. These include the
concentration of the target b cell antigen (Hosken et al.,
The inflammatory cytokine tumor necrosis factor 1995; Kurts et al., 1999b); inappropriate expression of
alpha (TNFa) has been linked to the development of costimulatory molecules on b cells coupled with pancre-
several autoimmune diseases. By adapting the tetra- atic inflammation (Guerder et al., 1994b, 1998; Herrera
cycline-regulated gene transcription system, we gen- et al., 1994, 2000; Herrath et al., 1995); and the localized
erated a murine model where islet-specific expression production of chemokines and cytokines that favor a
of TNFa could be repressed/derepressed within 48 hr detrimental Th1 over a protective Th2 environment and
following introduction/removal of tetracycline in the potentate the generation of cytotoxic effector islet-spe-
drinking water. Here we describe the temporal impor- cific CD81 T cells (Balasa et al., 1997, 1998; Green et
tance of TNFa in diabetes development in mice ex- al., 1998, 2000; Tian et al., 1998; Bradley et al., 1999;
pressing islet-specific B7-1 and TNFa. We show that Gallichan et al., 1999; Homann et al., 1999, to name but
the duration of TNFa-mediated inflammation, not the a few).
putative maturity of the immune system at the time of One common factor in all models for IDDM is the
TNFa expression, determines diabetes progression. necessity for an inflammatory response that leads to
Further, we have described an interval between 21 and the infiltration of the islets with immune cells. The inflam-
25 days following initiation of TNFa expression where matory cytokine tumor necrosis factor alpha (TNFa) is
the fate of islet-reactive T cells is decided. of particular interest with respect to the breakdown of
peripheral tolerance to islet antigen. Indeed, in C57BL/6
Introduction (B6) mice that are not genetically predisposed to devel-
oping diabetes, the transgenic coexpression of TNFa
combined with the expression of costimulatory mole-It is now well established that T cells reactive to host
cules on b cells results in rapid destruction of the bantigens can escape thymic deletion as a result of a
cells, whereas expression of costimulatory moleculesvariety of mechanisms. To compensate for this, self-
alone rarely leads to disease (Guerder et al., 1994a,reactive T cells can undergo tolerization in the periphery.
1998; Herrera et al., 1994). In the nonobese diabeticFor example, autoreactive T cells can be clonally deleted
(NOD) mouse that is genetically predisposed to developfollowing cross-presentation of host antigen by antigen-
IDDM, injection (Yang et al., 1994) or islet-specific ex-presenting cells (APCs), a mechanism that is irreversible
pression (Green et al., 1998) of TNFa in neonates accel-(Heath et al., 1998; Kurts et al., 1998a, 1998b). Alterna-
erates progression to diabetes. In contrast, adult injec-tively, self-reactive T cells that do not encounter their
tion (Jacob et al., 1990) or islet-specific expressionspecific antigen during normal recirculation are said to
(Grewal et al., 1996) of TNFa in adults protects againstbe ignorant of the antigen (Ohashi et al., 1991; Oldstone
diabetes. These studies suggest that TNFa can posi-et al., 1991). In addition, self-reactive T cells can be
tively or negatively regulate the breakdown of peripheralrendered anergic (Burkly et al., 1989, 1990). This latter
tolerance of islet-autoreactive T cells to b cell antigensmechanism can occur when self-reactive T cells en-
depending on the age of NOD mice (and thus the puta-counter their antigen on host tissue in the absence of
tive maturity of the immune system) at the time of expo-costimulatory molecules.
sure/expression.Inflammation as a result of, for example, viral or bacte-
However, there are at least four major concerns inrial infections has, for many years, been associated with
interpretation of the above data. First, it is unknownthe breakdown in peripheral tolerization and the pro-
whether the differences in diabetes progression follow-gression to autoimmunity (Ehl et al., 1998). Despite this
ing neonatal or adult injection of TNFa are related toassociation, the mechanisms by which inflammatory
the systemic administration of the cytokine. Second,mediators can overcome peripheral tolerization mecha-
although the transgenic models provide results consis-nisms remain elusive. In particular, it is unknown whether
tent with the data obtained by the systemic administra-the putative maturity of the immune system or the dura-
tion of TNFa studies, the data was acquired from twotion of the inflammation are critical parameters in break-
completely different transgenic lines that expressed
ing peripheral T cell tolerization (Forsthuber et al., 1996;
TNFa at different ages and potentially at different con-
Ridge et al., 1996; Sarzotti et al., 1996).
centrations. Thus, it is unknown whether the TNFa gene
insertion site or concentration of TNFa produced in the
two different models contributed to the results obtained.³ To whom correspondence should be addressed (e-mail: fran.manzo@
yale.edu). Third, the transgenic models rely on the constitutive
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of the rat insulin promoter, we created double-trans-
genic mice, termed Tet-TNFa mice, by coinjection of
the Tet0-TNFa and RIP-tTA gene constructs. We estab-
lish that islet-specific expression of TNFa can be con-
trolled by the presence or absence of tet in the water.
Tet-TNFa mice were crossed to RIP-B7-1 B6 mice that
constitutively express B7-1 in their islets to address
whether the putative maturity of the immune system
and/or duration of the TNFa-mediated inflammation
were critical parameters in the breakdown of peripheral
T cell tolerance to islet antigen in a genetic background
not predisposed to developing diabetes.
In the present study, we show that constitutive islet-
specific expression of TNFa in neonatal or adult Tet-
TNFa 3 RIP-B7-1 B6 mice breaks peripheral T cell toler-
ance to islet antigen irrespective of the putative maturity
of the immune system. In contrast, by selectively ex-
Figure 1. Generation of Tet-TNFa Mice pressing TNFa for different periods of time, we charac-
terize a period between 21 and 25 days following initia-Diagrammatic representation of the Tet0-TNFa and RIP-tTA con-
structs. The pRIP-tTA construct encodes the tetracycline-respon- tion of TNFa expression where the decision to progress
sive transactivating gene (tTA) under control of the rat insulin pro- from nondestructive to destructive insulitis is decided.
moter type II (RIPII). The pTet0-TNFa construct encodes the Our data provide novel insights into the relationship
genomic sequence for murine TNFa downstream from seven tetra-
between inflammation and autoimmunity by demonstra-cycline operator sequences linked to the minimal human cytomega-
ting that it is the duration of the inflammation that is thelovirus promoter (Tet0-hCMV). The major restriction sites are shown.
critical parameter for breakdown in peripheral T cellLocations of PCR 59 and 39 primers and the HIII±HIII probe used for
detection of transgenic TNFa mRNA are indicated. tolerance to host antigen.
Results
expression of TNFa in the islets and therefore cannot
Generation of Tet-TNFa Miceaddress whether acceleration or protection from auto-
To generate a transgenic model where islet-specific ex-immunity is dependent on the duration of the presence
pression of TNFa is mediated by a transcriptional on/offof TNFa in the islets. Most importantly, fourth, the data
switch, we took advantage of the tetracycline-regulatedcannot determine the importance of TNFa for breaking
gene transcription system (Gossen et al., 1995). First,or maintaining peripheral T cell tolerance to host antigen
the murine genomic sequence for TNFa was placedin mice not genetically predisposed to developing dia-
downstream of the tetracycline operator sequences,betes.
(Tet0-TNFa, Figure 1) and secondly, to ensure islet-spe-A murine model where islet-specific expression of
cific expression of TNFa, the gene encoding the tetracy-TNFa could be operated at will using a genetic switch
cline-responsive transactivating molecule (tTA) waswould be of great advantage for analyzing the relation-
placed under control of the rat insulin promoter II (RIP-ship between TNFa and the breakdown of peripheral T
tTA). Southern blot analysis of tail DNA determined thatcell tolerance to host antigens. In such mice, the gene
five founder mice had cointegration of the RIP-tTA andinsertion site and concentration of TNFa would remain
Tet0-TNFa transgenes (Tet-TNFa mice). All five lines ofthe same and thus would overcome two major obstacles
Tet-TNFa mice were backcrossed to C57BL/6 (B6) micethat occur in the analysis of two genetically different
for six generations prior to analysis.mice as described above.
Here we describe a novel transgenic model where
islet-specific expression of TNFa is mediated by a tran- Inducible TNFa Expression Is Restricted
to the Islets of Tet-TNFa Micescription on/off switch. This was achieved by adapting
the tetracycline-regulated gene transcription system The five Tet-TNFa founder lines, designated 9TNFa,
62TNFa, 63TNFa, 64TNFa, and 67TNFa, were assessed(Gossen and Bujard, 1992; Furth et al., 1994; Gossen et
al., 1995; Shockett et al., 1995; Shockett and Schatz, for tissue-specific expression of transgenic TNFa. All
mice were bred in the absence of tet and total RNA was1996). In this system, the repressor of the tetracycline-
resistant operon is fused to the activation domain of extracted from the pancreas, liver, kidney, lungs, heart,
thymus, and spleen of 18-day-old Tet-TNFa mice orviral protein 16 of herpes simplex virus (VP16), creating
a novel tetracycline-controlled transactivating protein their nontransgenic littermates (non-tg). Transgenically
encoded TNFa mRNA was measured by RT-PCR using(tTA). This tTA molecule can bind to tetracycline operator
sequence (Tet0) in the absence of tetracycline (tet) and primers specific for the Tet0-TNFa construct (Figure 1).
As controls for RNA quality, HPRT RNA levels were alsoinduce transcription from a minimal promoter like that
of human cytomegalovirus (CMV). In the presence of measured.
Lines 62TNFa, 63TNFa, 64TNFa, and 67TNFa con-tet, tTA fails to bind Tet0, and gene transcription is
repressed. tained TNFa mRNA, the expression being restricted to
the pancreas (Figure 2a). No TNFa mRNA was detect-By placing the murine genomic sequence for TNFa
downstream of Tet0 and the tTA molecule under control able in any tissue of line 9TNFa. Non-tg mice never
Duration of TNFa Signal Determine Autoimmunity
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Figure 2. Islet-Specific Expression of TNFa
Can Be Controlled by a Transcriptional On/
Off Switch
(a) TNFa expression is restricted to the pan-
creas of Tet-TNFa mice. cDNA was prepared
from various tissues of 18-day-old Tet-TNFa
mice that were bred in the absence of tet.
The cDNA from each tissue was normalized
by competitive HPRT RT-PCR, and the pres-
ence of transgenic TNFa cDNA was mea-
sured by RT-PCR and detected with a TNFa-
specific probe.
(b) Tet-TNFa mice develop insulitis in the ab-
sence of tet. Tet-TNFa mice or non-tg lit-
termates were bred in the absence of tet. At
10 weeks of age the mice were sacrificed and
the presence of immune cell infiltration in the
pancreas, liver, and kidney was assessed fol-
lowing hematoxylin/eosin staining of paraffin-
embedded sections.
(c) In vivo kinetics for TNFa derepression fol-
lowing removal of tet. Tet-TNFa mice were
placed on tet-supplemented water during
pregnancy. When the progeny were 12 days
old, the lactating mothers were placed on or-
dinary water to derepress TNFa expression.
Tet-TNFa or non-tg progeny were subse-
quently sacrificed 0, 24, and 48 hr later, and
the presence of TNFa mRNA in pancreata
was determined as before.
(d) Repression of TNFa expression prevents
insulitis. Tet-TNFa mice were bred in the
presence or absence of tet-supplemented
water. At 10 weeks of age the pancreas was
extracted and the presence of islet-infiltrating
cells was determined by hematoxylin/eosin
staining of paraffin-embedded sections.
expressed TNFa irrespective of the tissue examined. In TNFa and to establish the kinetics of repression. Initially,
we addressed the kinetics for TNFa expression/repres-addition, we measured TNFa protein levels secreted
from in vitro cultured islets. In all cases, barely ,1 pg/ml sion in suckling neonates to determine whether tet can
of TNFa could be measured. Nevertheless, histological pass from mother to suckling and repress TNFa tran-
analysis of the pancreas, liver, and kidney from 10-week- scription. Lines 63TNF, 64TNF, and 67TNFa were bred
old mice bred in the absence of tet demonstrated that in the presence of tet-supplemented water (0.3 g/l). Lac-
lines 63TNF, 64TNF, and 67TNF showed insulitis in the tating mothers were removed from tet-supplemented
pancreas (Figure 2b). There was no evidence of infiltra- water when the suckling neonates were 12 days old,
tion with immune cells in any other tissue examined. and the neonates were sacrificed 0, 24, and 48 hr later.
Lines 9TNFa and 62TNFa never developed insulitis (data In all lines examined, TNFa mRNA was first detected
not shown), suggesting that insufficient protein levels in neonatal pancreas 48 hr following withdrawal from
of TNFa were produced to induce infiltration. tet-supplemented water of lactating mothers (Figure 2c).
Similar studies to determine the kinetics of TNFa repres-
sion following placement of lactating mothers on tet-Tetracycline Can Rapidly Abrogate Islet-Specific
TNFa Expression supplemented water when their sucklings were 12 days
old established that 48 hr was the critical time point forTet-TNFa mice were further examined to determine
whether tet could abrogate islet-specific expression of TNFa transcription to be derepressed (data not shown).
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In addition, inhibition of TNFa expression also occurred
when the experiments were repeated in 8-week-old
adult Tet-TNFa mice. In these adult mice, the kinetics
for TNFa induction and repression were identical to that
seen for suckling neonates (data not shown).
Histological examination of pancreas isolated from
10-week-old Tet-TNFa mice that had been bred in the
presence or absence of tet-supplemented water dem-
onstrated that only mice bred in the absence of tet had
islet infiltration (Figure 2d). Thus, the constitutive ex-
pression of tTA molecules alone is not sufficient to in-
duce insulitis.
These findings highlight three major points: Tet-TNFa
mice express TNFa exclusively in their islets in the ab-
sence of tetracycline; TNFa expression can be inhibited
by introduction of tet into their drinking water; and since
the mice examined were suckling at the time of investi-
gation, passage of tet from the mother to pup can occur
at sufficient levels to inhibit TNFa gene transcription in
the pancreas.
The Putative Maturity of the Immune System Does
Not Affect Breakdown in Peripheral Tolerance
to Islet Antigen in C57BL/6 Mice
Time course histological and diabetes studies demon-
strated that all lines of Tet-TNFa mice had a phenotype
identical to that of RIP-TNFa B6 mice (Picarella et al.,
1993). For example, initiation of TNFa expression at birth
led to extensive infiltration of the islets with lymphocytes
and monocytes by 21 days of age, yet Tet-TNFa mice
never progressed to diabetes over a 1 year observation
period (n 5 50). Furthermore, when Tet-TNFa mice were
crossed to RIP-B7-1 B6 mice that express the costimu-
latory molecule B7-1 in their islets, all mice rapidly be-
came diabetic following initiation of TNFa expression at
birth. The kinetics for diabetes progression in these lat-
ter mice were similar to that reported for RIP-TNFa 3
RIP-B7-1 double-transgenic mice (Guerder et al., 1994b;
Herrera et al., 1994). These data highlighted the attrac- Figure 3. TNFa Induces Diabetes in Tet-TNFa 3 RIP-B7-1 Trans-
tiveness of Tet-TNFa mice for addressing whether the genic Mice Following Neonatal or Adult-Specific Expression of TNFa
ability of TNFa to break peripheral tolerance was depen- (a) Kinetics for diabetes progression following neonatal expression
of TNFa. Tet-TNFa 3 RIP-B7-1 mice were bred in the absencedent on the putative maturity of the immune system and/
(closed diamonds, n 5 30) or presence (checked squares, n 5 20) ofor the duration of the inflammatory response.
tet-supplemented water and the progression to diabetes monitoredWe decided to address these issues using the TNFa 3
over a 30 week observation period. As controls, RIP-TNFa 3 RIP-B7-1 B6 model of IDDM, because such mice are not
B7-1 (open squares, n 5 10), Tet-TNFa (closed circles, n 5 50), and
genetically predisposed to developing diabetes. As such, RIP-B7-1 (open triangles, n 5 30) were included in the assay.
they offer an exceptional model to test the importance (b) Adult-specific expression of TNFa promotes diabetes in Tet-
TNFa 3 RIP-B7-1 mice. Tet-TNFa 3 RIP-B7-1 mice (closed dia-of TNFa in breakdown of peripheral tolerance without
monds, n 5 15) were bred in the presence of tet-supplementedthe complications arising from unidentified genetic
water. At 6 weeks of age, TNFa expression was derepressed byfactors.
withdrawing tet from the water and the progression to diabetesFirst, we asked whether the putative maturity of the
monitored as before. As controls, RIP-TNFa 3 RIP-B7-1 (open
immune system at the time of inflammation determined squares, n 5 8), Tet-TNFa (closed circles, n 5 15), and RIP-B7-1
the autoimmune fate of Tet-TNFa 3 RIP-B7-1 mice. All (open triangles, n 5 15) were similarly bred in the presence of tet-
supplemented water until 6 weeks of age, after tet was withdrawnthree lines, 63TNF, 64TNF, and 67TNF, were analyzed
from the water.and gave identical results. Therefore, the mice will sub-
sequently be identified simply as Tet-TNFa mice in the
following data. ance in a mature immune system, we initiated TNFa
expression at 6 weeks of age in Tet-TNFa 3 RIP-B7-1RIP-B7-1 B6 mice were crossed with Tet-TNFa mice
creating Tet-TNFa 3 RIP-B7-1 transgenic mice. To as- mice. In both cases, the development of diabetes was
monitored. As controls, RIP-B7-1, Tet-TNFa, and RIP-sess the importance of inflammation in breaking periph-
eral tolerance of an immature immune system, TNFa B7-1 3 RIP-TNFa B6 mice were included in the experi-
ments.expression was initiated at birth in Tet-TNFa 3 RIP-B7-1
mice. To test if inflammation influenced peripheral toler- Initiation of TNFa in neonatal Tet-TNFa 3 RIP-B7-1
Duration of TNFa Signal Determine Autoimmunity
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suggesting TNFa was no longer required for diabetes
development after b cell destruction is initiated. Interest-
ingly, repression of TNFa expression after initiation of
insulitis at 21 days prevented the development of diabe-
tes (Figure 4). We expanded on this finding to determine
how long TNFa had to be expressed in the islets to
promote diabetes development in Tet-TNFa 3 RIP-B7-1
mice. By repressing TNFa at days 21, 25, and 30 follow-
ing initiation of TNFa expression at birth, we established
that TNFa had to be expressed for a minimum of 25 days
for absolute progression to diabetes in Tet-TNFa 3
RIP-B7-1 mice (Figure 4). Another intriguing parameter
was the kinetics of diabetes development following re-
pression of TNFa at either 25 or 30 days of age. Whereas
repression of TNFa at 30 days of age resulted in diabetes
by 49 days of age, repression of TNFa at 25 days of age
did not induce diabetes until 84 days of age (Table 1).
These data highlight an important point in the relation-
Figure 4. Diabetes Development in Tet-TNFa 3 RIP-B7-1 Mice Is ship between TNFa and the breakdown of peripheral T
Dependent on the Duration of TNFa Expression cell tolerance to host cells: TNFa-mediated inflamma-
TNFa expression was induced at birth in Tet-TNFa 3 RIP-B7-1 mice tion coupled with inappropriate expression of costimula-
then repressed at 10 (closed circles, n 5 10), 21 (open diamonds, tory molecules on host cells does not preclude autoim-n 5 15), 25 (open circles, n 5 18), or 30 (closed diamonds, n 5 10)
munity. Instead, the duration of the TNFa-mediateddays of age and the progression to diabetes monitored. As a control,
inflammation is critical for determining whether periph-in a separate group of Tet-TNFa mice, TNFa expression was never
repressed (open squares, n 5 25) and the progression to diabetes eral tolerance to islet antigen is broken. Further, the
similarly monitored. longer TNFa is present, the more rapid breakdown in
tolerization mechanisms occur.
mice resulted in diabetes by 6±9 weeks of age, with
CD81 T Cell Infiltration of Islets Correlates100% incidence of disease by 9 weeks of age (Figure 3a).
with the Breakdown in Peripheral T CellThis time frame for diabetes development was similar
Tolerance to Islet Antigento that of RIP-B7-1 3 RIP-TNFa B6 double-transgenic
The development of diabetes in RIP-TNFa 3 RIP-B7-1mice, in which diabetes started at 5 weeks of age, and
mice is CD81 T cell dependent and CD41 T cell indepen-all mice developed diabetes by 6 weeks of age. Diabetes
development in either group of mice was dependent on dent (Herrera et al., 1994). Infiltration of islets normally
the expression of TNFa on their islets, since single- follows a sequence where APCs enter first, then CD41
transgenic RIP-B7-1 mice never developed disease T cells with CD81 T cells enter last (Green et al., 1998).
(Guerder et al., 1994b). Diabetes development was also One possible explanation, therefore, to account for why
apparent following initiation of TNFa in 6-week-old adult repression of TNFa at 21 days of age stops progression
Tet-TNFa 3 RIP-B7-1 mice, the kinetics of diabetes devel- to diabetes in Tet-TNFa 3 RIP-B7-1 mice is that TNFa
opment being similar to that seen for the studies in neo- repression occurs prior to the recruitment of CD81 T
nates (Figure 3b). Thus, diabetes started in the colony cells to the islets. This hypothesis precludes that CD81
about 6 weeks following initiation of TNFa expression with T cells infiltrate the islets due to the TNFa-mediated
100% of mice diabetic by 15 weeks of age. inflammatory signal. Further, since repression of TNFa
The constitutive expression of TNFa can therefore at day 25 still leads to diabetes, CD81 T cells must be
promote breakdown in peripheral tolerance to host anti- recruited to the islets between 21 and 25 days of age.
gen irrespective of the putative maturity of the immune We tested this hypothesis by performing histological
system. studies as a function of time.
TNFa expression was initiated at birth in Tet-TNFa 3
RIP-B7-1 mice and then repressed at either 21 or 25The Duration of the TNFa Signal Determines the
Diabetic Fate of Tet-TNFa 3 RIP-B7-1 Mice days of age. Animals were sacrificed at 21, 25, and 84
days of age, and the pancreas was extracted for analy-Another important parameter relating to the ability of
TNFa to negatively influence peripheral T cell tolerance sis. By 21 days, the number of infiltrating DCs, DC/M`,
B cells, and CD41 T cells were clearly present (data notcould be the duration of the TNFa signal. We addressed
this by performing a series of diabetes studies where shown), but CD81 T cells were absent (Figure 5a). In
contrast, CD81 T cells were clearly evident in the isletsTNFa was repressed at defined ages in the Tet-TNFa 3
RIP-B7-1 mice. Initially we selected three time points of 25-day-old Tet-TNFa 3 RIP-B7-1 mice (Figure 5b).
DCs, DC/M`, B cells, and CD41 T cells were also pres-for repression of TNFa expression: prior to insulitis (10
days of age), during insulitis but prior to b cell damage ent at this time point (data not shown). To confirm that
CD81 T cells are not recruited latently to the islets follow-(21 days of age), and following the first evidence of b
cell damage (30 days of age). ing repression of TNFa at 21 days of age, we also exam-
ined the pancreas from 84-day-old Tet-TNFa 3 RIP-B7-1Repression of TNFa in 10-day-old neonates prevented
development of both insulitis and diabetes as expected. mice. As a control, we included pancreas from 84-day-
old animals in which TNFa expression was repressedIn contrast, repression of TNFa expression at 30 days
of age did not abrogate b cell destruction (Figure 4), at 25 days of age. To our surprise, we could not find
Immunity
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Table 1. Kinetics of Diabetes Progression in Tet-TNFa 3 RIP-B7-1 Mice Depending on the Duration of TNFa-Mediated Inflammation
Age of Mice When Age at Which
Group Size TNFa Was Repressed Number Diabetic Diabetes Develops
25 never repressed 25/25 35±42 days
15 21 days 0/15 N/A
18 25 days 18/18 77±84 days
10 30 days 10/10 42±49 days
All mice were induced to express TNFa at birth; then, TNFa was repressed at the times shown and the progression to diabetes monitored
over a 30 week observation period.
infiltrating cells in the islets of 84-day-old mice in which point influenced the progression to diabetes and/or in-
sulitis.TNFa expression was repressed at 21 days of age
(Figure 5c, n 5 19). Repression of TNFa at 25 days TNFa was induced at birth in Tet-TNFa 3 RIP-B7-1
mice, and on days 15, 17, and 19, the neonates wereof age resulted in complete destruction of the insulin-
producing b cells and diabetes development (Figure 5d, injected with either anti-CD8 antibodies (Abs, 53-6.7) or
an isotype control Abs. TNFa expression was subse-n 5 10).
These data suggest that one reason the duration of quently repressed at day 25, and all mice were moni-
tored for diabetes development over a 180 day observa-the TNFa-inflammatory signal is critical for breakdown
in peripheral T cell tolerance to islet antigen may relate tion period. Both immunohistochemistry and FACS
analysis confirmed the efficacy of this anti-CD8 Ab re-to the creation of an environment that can sustain the
survival and/or retention of insulitis and recruitment of gime at depleting CD81 T cells from Tet-TNFa 3 RIP-
B7-1 mice between 21 and 25 days of age (data notCD81 T cells.
shown). Further, neither Ab had any effect on APC or
CD41 T cell numbers or infiltration in the islets.Preventing CD81 T cell Infiltration of Islets between 21
and 25 Days of Age Blocks Diabetes Progression Isotype control±treated mice started to develop dia-
betes 7 weeks after repression of TNFa at 25 days,in Tet-TNFa 3 RIP-B7-1 Mice
We further investigated the importance of CD81 T cell with all mice being diabetic 11 weeks following TNFa
repression (Figure 6a). These kinetics and penetranceinfiltration of the islets in Tet-TNFa 3 RIP-B7-1 mice
between 21 and 25 days of age by addressing whether are similar to those seen for nonantibody-treated mice
in which TNFa was repressed at day 25. In contrast, 7/8the removal of CD81 T cells during this restricted time
Figure 5. Recruitment of CD81 T Cells to the
Islets Correlates with Maintenance of Insulitis
TNFa expression was induced at birth in Tet-
TNFa 3 RIP-B7-1 mice, and on day 21 (a and
c) or day 25 (b and d) TNFa expression was
repressed. The presence of CD81 T cells in
the islets 21 (a) or 25 (b) days following initia-
tion of TNFa expression was determined by
immunohistochemistry. Alternatively, the mice
were sacrificed on day 84 following TNFa re-
pression at day 21 (c) or day 25 (d) and the
severity of insulitis determined by hemotoxy-
lin and eosin staining of paraffin-embedded
sections. The data is representative of 10 in-
dividual mice examined at each time point.
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Figure 6. CD81 T Cells Recruited to the Islets
in the Absence of TNFa Do Not Induce Diabe-
tes in Tet-TNFa 3 RIP-B7-1 Mice
(a) Anti-CD8 treatment prevents diabetes in
Tet-TNFa 3 B7-1 mice if TNFa is repressed
at 25 days of age. TNFa was induced at birth
in Tet-TNFa 3 RIP-B7-1 mice and on days
15, 17, and 19 the mice were injected with
53-6.7 anti-CD8 antibody (closed diamonds,
n 5 8) or isotype control antibody (open
squares, n 5 8), or received no antibody treat-
ment (closed circles, n 5 12). TNFa expres-
sion was repressed at day 25 and the pro-
gression to diabetes monitored over a 26
week observation period.
(b) Histological examination of islet-infiltrat-
ing cells in 17-week-old anti-CD8-treated
Tet-TNFa 3 B7-1 mice, where TNFa expres-
sion was repressed at day 25. Pancreata were
excised and the presence of CD41, CD81,
B2201 cells (purple) or insulin (green) were
determined.
anti-CD8-treated mice never developed diabetes over determined that CD81 T cells were present in the islets
as early as 3 weeks following the last anti-CD8 antibodya 27 week observation period. The one mouse that did
develop diabetes did so with kinetics similar to isotype treatment and were consistently detectable at 17 (Figure
6b) and 27 weeks of age (data not shown). Despite thiscontrol±treated mice.
It was possible that the lack of progression to diabetes presence of CD81 T cells in the islets, there was no
evidence that there was a decrease in the insulin-pro-in anti-CD8-treated Tet-TNFa 3 RIP-B7-1 mice was due
to an inability of CD81 T cells to be recruited to the islets ducing b cells (Figure 6b). CD41 T cell, B cell, and den-
dritic cell (data not shown) infiltration was also clearlyfollowing repression of TNFa at day 25. However, this
was not the case since time course histological studies evident at all time points analyzed.
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These data highlight two major points: first, CD81 T tissue in breaking peripheral tolerance was highlighted
by the evidence that coexpression of B7-1 and TNFacells can be recruited to the islets in the absence of
on b cells induced diabetes in nonautoimmune pronetransgenic TNFa signals, and second, the recruitment
B6 mice (Guerder et al., 1994b, 1998; Herrera et al.,of CD81 T cells to the islets and the subsequent encoun-
1994, 2000). Although these previous studies providedter with B7-1 on host b cells in the absence of transgenic
exceptional insights into the conditions that led to theTNFa is not sufficient to break peripheral tolerance to
breakdown in peripheral tolerance, they could not ad-islet antigen as previously believed.
dress two important issues. First, was the ability to break
peripheral tolerance in RIP-TNFa 3 RIP-B7-1 B6 miceDiscussion
a characteristic of the neonatal immune system? For
this to be true, peripheral tolerization of islet-reactive TThe tetracycline-regulated transcriptional control of is-
cells must occur exclusively during the neonatal period.let-specific expression of TNFa has greatly facilitated
Alternatively, peripheral tolerization may be a continualthe analysis of the relationship between inflammation
process and not restricted to neonates. In this instance,and breaking peripheral tolerance to islet antigen. In
islet-reactive T cells would either have to be long livedparticular, we have been able to address whether the
or continually egress from the thymus. Our data supportputative maturity of the immune system at the time of
the latter hypothesis. We established that initiation ofinflammation or the duration of the inflammation deter-
TNFa expression at birth or in adult Tet-TNFa 3 RIP-mines the autoimmune outcome. Our system has over-
B7-1 mice (.6 weeks of age) resulted in diabetes withcome many obstacles presented by the traditional trans-
similar penetrance and kinetics. This suggests that pe-genic approach. For example, adult expression of TNFa
ripheral deletion of islet-reactive T cells does not occuris not dependent on the random insertion of the desired
exclusively during the neonatal period (Carlow et al.,gene close to DNA sequences that prevent activation
1992). Further, although it is possible that T cell igno-of RIPs until adulthood. Further, it avoids the problems
rance (Ohashi et al., 1991; Oldstone et al., 1991) or an-associated with the interpretation of the results from
ergy (Burkly et al., 1989, 1990) of islet-reactive T cellstwo completely different transgenic lines that express
may occur in the neonatal period, such tolerance isa particular molecule at different ages and potentially
reversed in adults by the initiation of TNFa expression.at different concentrations. In addition, it facilitates the
The second issue that could not be addressed in theanalysis of the effect that both constitutive and re-
original RIP-TNFa 3 RIP-B7-1 studies was whetherstricted expression of TNFa has on breakdown in pe-
breakdown in peripheral tolerance to islet antigen re-ripheral tolerance.
quired the continual presence of the inflammatory sig-By placing the murine sequence for TNFa downstream
nal. Our data clearly establish that the continual pres-of tetracycline-responsive operator sequences and the
ence of TNFa in the islets is not a prerequisite forgene encoding the tetracycline-responsive transactivat-
breakdown in peripheral tolerance to islet antigen. Thising protein under control of RIP, we could control TNFa
is based on the observation that repression of TNFa 25expression in the islets of double-transgenic Tet-TNFa
days following initiation of expression was sufficient tomice depending on the presence or absence of tet in
induce diabetes. In contrast, repression of TNFa 21 daystheir water. Tet-TNFa mice constitutively expressing
following initiation of expression leads to insulitis butTNFa were phenotypically indistinguishable from the un-
not diabetes. Thus, although the continual presence ofregulated RIP-TNFa B6 mice, developing insulitis as
TNFa-mediated inflammation is not necessary for theearly as 12 days following initiation of TNFa at birth yet
development of diabetes, there is a minimum duration
never progressing to diabetes over a 1 year observation
that TNFa has to be expressed for peripheral tolerance
period. Tet-TNFa mice in which TNFa was not induced
of T cells to be overcome. Furthermore, kinetic studies
exhibited no insulitis at any time examined, suggesting demonstrated that the longer TNFa was expressed, the
that there was no leakiness of transgene expression as more rapid the breakdown in peripheral tolerance of
reported for others (Shockett and Schatz, 1996). Such islet-reactive T cells was promoted. We originally hy-
mice also did not develop diabetes, even when B7-1 was pothesized that the requirement for a 25-day duration
transgenically expressed on the b cells. These findings in expression of TNFa in the development of diabetes
demonstrated that the constitutive expression of the related to the length of time it took to activate and recruit
tTA molecule (under control of RIP) was not toxic since effector autoaggressive CD81 T cells to the islets. This
it induced neither insulitis nor diabetes. was based on the evidence that diabetes' development
in the RIP-TNFa 3 RIP-B7-1 system is CD81 T cell de-
The Duration of TNFa-Mediated Inflammation pendent (Herrera et al., 1994, 2000) and histological
Predicts the Autoimmune Outcome studies demonstrating that infiltration of islets with im-
It is now well established that thymic tolerance is not mune cells is normally sequential; first infiltrates are
absolute. Indeed, autoreactive T cells are readily de- composed of antigen-presenting cells and subsequently
tected in the periphery. In normal circumstances, auto- CD41 T cells, with CD81 T cells entering last. Our immu-
immunity does not occur since parenchymal tissue fails nohistochemical analysis of islet-infiltrating cells be-
to express the costimulatory molecules required for T tween 21 and 25 days following the initiation of TNFa
cell activation. In addition, access of naive T cells to expression supported this hypothesis since they dem-
host tissue is normally limited (Alferink et al., 1998) since onstrated that during this time point CD81 T cells are
noninflamed endothelium is not permissive for T cell recruited to the islets. Further, FACS analysis demon-
extravasation. The importance of inflammation coupled strated that these infiltrating CD81 T cells at day 25
expressed CD25 and had started to differentiate intoto aberrant expression of B7-1 or B7-2 on parenchymal
Duration of TNFa Signal Determine Autoimmunity
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perforin-positive CTL (data not shown). However, our determined. Our data provide novel insights into the
subsequent studies suggested recruitment of CD81 T relationship between inflammation and autoimmunity
cells to the islets, although necessary, was not in itself and will hopefully facilitate the development of new ther-
sufficient to induce diabetes. This was suggested by apeutic strategies directed toward diabetes and other
the data demonstrating that depletion of CD81 T cells TNFa-mediated autoimmune diseases.
during this crucial 21±25 day period after initiation of
TNFa expression resulted in CD81 T cell infiltration of Experimental Procedures
the islets by 6 weeks of age, but such mice did not
Micedevelop diabetes so long as TNFa expression was re-
RIP-TNFa and RIP-B7-1 B6 mice have been described elsewherepressed at day 25. It is worth noting that a similar pattern
(Picarella et al., 1993; Guerder et al., 1994a). RIP-TNFa mice consti-of infiltration occurred following initiation of TNFa ex- tutively express TNFa in their islets from birth, develop insulitis but
pression at 6 weeks of age, and repression of TNFa not diabetes. RIP-B7-1 mice constitutively express B7-1 in their
prior to infiltration of CD81 T cells prevented disease islets from birth and rarely develop diabetes. Plasmid pTet-tTAk that
encodes the tetracycline-responsive transactivator under control ofprogression. These data suggest but do not prove that
the enhancer/promoter sequences of the immediate-early gene ofdiabetes development following expression of TNFa in
human cytomegalovirus (hCMV) and the simian virus 40 (SV40) smallneonatal and adult mice may be similar. We are currently
T antigen intron and polyadenylation sequence downstream fromestablishing if this is the case.
tTA has been described previously (Shockett et al., 1995). pTet-tTAk
There are at least three possible hypotheses as to was cleaved at the SacI±HindIII sites and hCMV replaced with the
why CD81 T cells that enter the islet following repression rat insulin promoter type II, (RIPII) creating pRIP-tTA (Figure 1).
of TNFa do not destroy the B7-1-expressing b cells. The RIP-tTA transgene was isolated as a 3.8 kb fragment following
double digestion of pRIP-tTA with NotI and ScaI.The first is based on existing models for CD81 T cell
Plasmid pTet-Splice that encodes seven tetracycline-responsivedestruction of b cells that suggest diabetes develop-
operator sequences linked to hCMV (Shockett et al., 1995) wasment requires the initial priming of islet-reactive CD81
digested with PvuII and EcoRV and the hCMV-Tet0 sequence iso-
T cells in the pancreatic lymph node followed by their lated. The plasmid pRIP-TNFa, which encodes the genomic se-
recruitment and secondary activation/expansion in situ quence for murine TNFa downstream from the rat insulin II promoter,
in the islet (Kurts et al., 1999a). Thus, it is possible that was cleaved with NotI, blunted with Klenow fragment, and then
redigested with EcoRV, effectively removing RIPII. Next, the hCMV-CD81 T cells recruited to the islets in the absence of
Tet0 sequence was inserted into modified plasmid, creating pTet0-TNFa do not receive the necessary signals to undergo
TNFa (Figure 1). The Tet0-TNFa transgene was isolated as a 3.6 kbsecondary activation/expansion. The second is based
fragment following double digestion of pTet0-TNFa with XhoI andon the hypothesis that priming of islet-reactive T cells
XmnI.
occurs in situ in the islet. In this instance, the repression Both fragments were purified using Elutip purification columns
of TNFa may lead to reduction of the level of MHC- (Schleicher and Schuell, Keene, NH) and coinjected into the pronu-
peptide complexes on islet-infiltrating APCs below the clei of (C57BL/6 3 C3H) F2 mice. Double transgene±positive found-
ers were identified by Southern blot analysis using an EcoRI±EcoRIthreshold necessary for CD81 T cell priming, and thus,
probe from pRIP-tTA and a HindIII±HindIII probe from pTet0-TNFarecruitment of CD81 T cells in the absence of TNFa
plasmid (Figure 1).expression prevents CD81 T cell priming. The third hy-
pothesis states that autoregulatory mechanisms that
cDNA Synthesis and RT-PCR
have been documented in certain inflammatory diseases Total pancreatic RNA was prepared by guanidine thiocyanate ex-
(Read et al., 1998; Suri-Payer et al., 1998; Thornton and traction (Chomczynski and Sacchi, 1987). For all other tissues, total
Shevach, 1998, 2000; Asseman et al., 1999) are operative RNA was prepared by TRIzol reagent (GIBCO±BRL, Life Technolo-
gies, Gaithersburg, MD) following the manufacturer's recommenda-in Tet-TNFa 3 RIP-B7-1 mice and actively suppress
tions. cDNA was prepared by standard procedures and the concen-the anti-islet CD81 T cell response in situ. This latter
tration of cDNA from each tissue quantitated by competitive PCRhypothesis suggests that between 21 and 25 days fol-
using primers specific for HPRT (Reiner et al., 1993). Transgeniclowing initiation of TNFa expression, the islets become
TNFa was measured by RT-PCR using a 59 primer downstream from
infiltrated with immune cells capable of actively sup- hCMV-1 (59-GACCTCCATAGAAGACACC-39) and a 39 primer specific
pressing anti-islet CD81 T cell responses. It follows that for exon II of the murine TNFa gene (Green et al., 1998). PCR prod-
islet infiltration of CD81 T cells in the presence of TNFa ucts were blotted onto nitrocellulose and probed with a TNFa-spe-
cific probe (Figure 1). All primer sequences were synthesized in theprovides the necessary signals for CD81 T cells to di-
Keck Facility (Yale University).rectly or indirectly overcome these autoregulatory T
cells. We are currently determining whether these three
Histologyhypotheses are mutually exclusive.
Tissues were prepared for histology by fixation in 15% formalde-In conclusion, through the development of a trans-
hyde, and 5±7 mm sections of paraffin-embedded tissue were
genic model where islet-specific expression of TNFa stained with hematoxylin and eosin. Alternatively, tissues were fixed
can be regulated by a transcriptional on/off switch, we in 1% paraformaldehyde and passed through sucrose gradients
have established that the duration of the inflammatory before freezing in Tissue-Tek OCT (Bayer, Elkhart, IN) (Picarella et
al., 1993). CD41 T cells, CD81 T cells, and B2201 B cells weresignal is a major criteria in the breakdown of peripheral
detected using biotinylated antibodies (PharMingen, San Diego, CA)tolerance to host antigens in animals not genetically
followed by phosphatase streptavidin and BCIP/NBT substratepredisposed to developing autoimmunity. By selectively
(Zymed, San Francisco, CA). Insulin was detected using guinea pigexpressing TNFa for short periods of time, we have been
anti-insulin Ab (Biogenex, San Ramon, CA) followed by fluroscein
able to analyze the importance of inflammation from the isothycynate±labeled anti-guinea pig Ab (Sigma, St. Louis, MO).
initiation of insulitis to diabetes progression. In particu-
lar, we have identified a short window of 21±25 days Tetracycline and Antibody Treatment
following initiation of TNFa expression where the fate Animals were treated with tetracycline by supplementation of drink-
ing water with 0.3 g/l of tetracycline hydrochloride (Sigma) and 5%of autoreactive T cells (activation versus tolerance) is
Immunity
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aspartame (NutraSweet, Deerfield, IL). Water was changed every 4 Furth, P., Onge, S.L., Boger, H., Gruss, P., Gossen, M., Kistner, A.,
Bujard, H., and Hennighausen, L. (1994). Temporal control of genedays.
For CD81 T cell depletion in vivo, mice were injected on 15, 17, expression in transgenic mice by a tetracycline-responsive pro-
moter. Proc. Natl. Acad. Sci. USA 91, 9302±9306.and 19 days of age intraperitoneally with either anti-CD8 antibody
(5.6-7, ATCC, Rockville, MD) or isotype control antibody, both of Gallichan, W., Balasa, B., Davies, J., and Sarvetnick, N. (1999). Pan-
which had been purified by affinity chromatography. All mice re- creatic IL-4 expression results in islet-reactive Th2 cells that inhibit
ceived 500 mg of antibody on each occasion. diabetogenic lymphocytes in the nonobese diabetic mouse. J. Im-
munol. 163, 1696±1703.
Diabetes Testing Gossen, M., and Bujard, H. (1992). Tight control of gene expression
Diabetes was monitored by weekly testing of urine for glucose using in mammalian cells by tetracycline-responsive promoters. Proc.
Diastyx sticks (Bayer) and confirmed by measurement of glucose Natl. Acad. Sci. USA 89, 5547±5551.
levels in serum using One-Touch strips (Lifescan, Milpitas, CA).
Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., andAnimals that had values of .250 mg/dl on two consecutive occa-
Bujard, H. (1995). Transcritional activation by tetracyclines in mam-sions were deemed diabetic.
malian cells. Science 268, 1766±1769.
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